跳至主要内容
临床试验/NCT04653077
NCT04653077Unknown不适用

Bone Marrow Stem Cells Transplantation for the Treatment of Cerebral Palsy

Aljazeera Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年12月2日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Changes in Motor Performance.

研究概览

简要总结

Cerebral palsy (CP) is the most common physical disability in childhood. CP comprises a heterogeneous group of disorders that are the result of a non-progressive disruption or injury that occurred during fetal brain development or within the first two years of life.

详细描述

This disruption can result in spasticity, dystonia, muscle contractures, weakness and difficulty in coordination that ultimately affects the ability to control movements. Resultant activity limitations may affect gross motor movements, fine motor movements, speech and communication, as well as eating and drinking.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • • Must be more than 2 year of age and less than 12 years of age at the time of screening for inclusion in the study.
  • Clinical evidence of a non-progressive motor disability due to brain dysfunction.

排除标准

  • • Intractable seizures
  • Traumatic brain injury
  • Genetic disorder
  • Current Infection
  • Renal insufficiency
  • Hepatic disease
  • HIV+ (as demonstrated by positive blood test)
  • Immunosuppression

结局指标

主要结局

Changes in Motor Performance.

时间窗: 6 months

the number of patients who will have changes in motor performance

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

MSCs Therapy for Cerebral Palsy | 临床试验